Novartis AG

Historical 13F Holders

Symbol
NVS
CUSIP
66987V109
All holders as of
Q1 2025
Type
Equity
Class
SPONSORED ADR
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 1,366 139 M $15.4 B
2024 Q4 1,358 130 M $12.7 B
2024 Q3 1,344 132 M $15.2 B
2024 Q2 1,349 145 M $15.5 B
2024 Q1 1,283 155 M $15.0 B
2023 Q4 1,305 152 M $15.3 B
2023 Q3 1,253 149 M $15.1 B
2023 Q2 1,239 149 M $15.0 B
2023 Q1 1,216 176 M $15.3 B
2022 Q4 1,227 173 M $16.1 B
2022 Q3 1,123 184 M $14.0 B
2022 Q2 1,166 200 M $16.9 B
2022 Q1 1,168 209 M $18.3 B
2021 Q4 1,179 211 M $18.5 B
2021 Q3 1,114 220 M $18.0 B
2021 Q2 1,149 217 M $19.8 B
2021 Q1 1,170 219 M $18.7 B
2020 Q4 1,224 231 M $22.2 B
2020 Q3 1,170 226 M $19.7 B
2020 Q2 1,174 238 M $20.8 B
2020 Q1 1,184 249 M $20.5 B
2019 Q4 1,218 260 M $24.6 B
2019 Q3 1,132 244 M $21.3 B
2019 Q2 1,154 259 M $23.7 B
2019 Q1 1,179 274 M $26.2 B
2018 Q4 1,123 273 M $23.4 B
2018 Q3 1,068 261 M $22.5 B
2018 Q2 1,017 257 M $19.4 B
2018 Q1 1,046 256 M $20.7 B
2017 Q4 1,039 251 M $21.1 B
2017 Q3 971 259 M $22.2 B
2017 Q2 955 260 M $21.7 B
2017 Q1 941 272 M $20.2 B
2016 Q4 937 255 M $18.6 B
2016 Q3 910 239 M $18.9 B
2016 Q2 911 237 M $19.6 B
2016 Q1 903 239 M $17.3 B
2015 Q4 961 236 M $20.4 B
2015 Q3 953 234 M $21.5 B
2015 Q2 972 236 M $23.2 B
2015 Q1 966 234 M $23.6 B
2014 Q4 957 236 M $22.4 B
2014 Q3 914 234 M $22.6 B
2014 Q2 877 239 M $22.2 B
2014 Q1 866 238 M $20.8 B